A case of post-COVID-19 myalgic encephalomyelitis/chronic fatigue
syndrome characterized by post-exertional malaise and low serum
acylcarnitine level
Abstract
COVID-19 afflicts patients with acute symptoms and longer-term sequelae.
One of the sequelae is myalgic encephalomyelitis/chronic fatigue
syndrome (ME/CFS), which is often difficult to diagnose, having no
established tests. In this article, we synthesize information from
literature reviews on patients with ME/CSF that developed after recovery
from COVID-19.